Latest News

CAP Opens Comment Period for MMR/MSI Testing, Advancing Care for Patients with Cancer

NORTHFIELD, Ill.–(BUSINESS WIRE)– #pathologists–Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP) and three collaborating societies are developing a clinical guideline for testing DNA mismatch repair (MMR) and microsatellite instability (MSI) status in patients with a range of cancer types. Today, the groups open the public comment period for the guideline “MMR and MSI Testing in Patients Bei

Source link

Related posts

MPEG LA Issues Statement Regarding CRISPR Patent Licensing


5 Ways To Speed Up Wound Healing


Shocking Life After Death Proof Revealed By Scientist


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy